Inhibition of woodchuck hepatitis virus gene expression in primary hepatocytes by siRNA enhances the cellular gene expression

Virology

Volumn 384, Issue 1, 2009, Pages 88-96

  Meng, Zhongji ^a,c   Qiu, Song ^a,b   Zhang, Xiaoyong ^a,b   Wu, Jun ^a,b   Schreiter, Thomas ^a   Xu, Yang ^b   Yang, Dongliang ^b   Roggendorf, Michael ^a   Schlaak, Jörg ^a   Lu, Mengji ^a,b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Hepadnavirus; IFN stimulated genes; ISGs; RNA interference; RNAi; Woodchuck

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE REPLICATION; GENETIC TRANSFECTION; HEPATITIS; HEPATITIS B VIRUS; HEPATITIS VIRUS; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RNA INTERFERENCE; TRANSCRIPTION INITIATION; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; CELL LINE; CRICETINAE; GENE EXPRESSION REGULATION, VIRAL; HEPATITIS B VIRUS, WOODCHUCK; HEPATOCYTES; HUMANS; MARMOTA; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA, VIRAL; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

HEPADNAVIRIDAE; HEPATITIS B VIRUS; MARMOTA MONAX; WOODCHUCK HEPATITIS VIRUS;

EID: 58549120152     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.11.012     Document Type: Article

References (53)

1. Baccarani U., Sanna A., Cariani A., Sainz-Barriga M., Adani G.L., Zambito A.M., Piccolo G., Risaliti A., Nanni-Costa A., Ridolfi L., Scalamogna M., Bresadola F., and Donini A. Isolation of human hepatocytes from livers rejected for liver transplantation on a national basis: results of a 2-year experience. Liver Transpl. 9 (2003) 506-512
2. Bartlett D.W., and Davis M.E. Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Res. 34 (2006) 322-333
3. Boni C., Bertoletti A., Penna A., Cavalli A., Pilli M., Urbani S., Scognamiglio P., Boehme R., Panebianco R., Fiaccadori F., and Ferrari C. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J. Clin. Invest. 102 (1998) 968-975
4. Boni C., Penna A., Ogg G.S., Bertoletti A., Pilli M., Cavallo C., Cavalli A., Urbani S., Boehme R., Panebianco R., Fiaccadori F., and Ferrari C. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 33 (2001) 963-971
5. Boni C., Penna A., Bertoletti A., Lamonaca V., Rapti I., Missale G., Pilli M., Urbani S., Cavalli A., Cerioni S., Panebianco R., Jenkins J., and Ferrari C. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J. Hepatol. 39 (2003) 595-605
6. Bridge A.J., Pebernard S., Ducraux A., Nicoulaz A.L., and Iggo R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34 (2003) 263-264
7. Chisari F.V., and Ferrari C. Hepatitis B virus immunopathology. Springer Semin. Immunopathol. 17 (1995) 261-281
8. Chiu Y.L., and Rana T.M. siRNA function in RNAi: a chemical modification analysis. RNA. 9 (2003) 1034-1048
9. Dahmen A., Herzog-Hauff S., Bocher W.O., Galle P.R., and Lohr H.F. Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B. J. Med. Virol. 66 (2002) 452-460
10. Fernandez M., Quiroga J.A., and Carreno V. Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins. J. Gen. Virol. 84 (2003) 2073-2082
11. Foster G.R., Ackrill A.M., Goldin R.D., Kerr I.M., Thomas H.C., and Stark G.R. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 2888-2892
12. Giladi H., Ketzinel-Gilad M., Rivkin L., Felig Y., Nussbaum O., and Galun E. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol. Ther. 8 (2003) 769-776
13. Gilot D., Serandour A.L., Ilyin G.P., Lagadic-Gossmann D., Loyer P., Corlu A., Coutant A., Baffet G., Peter M.E., Fardel O., and Guguen-Guillouzo C. A role for caspase-8 and c-FLIPL in proliferation and cell-cycle progression of primary hepatocytes. Carcinogenesis 26 (2005) 2086-2094
14. Guo Y., Guo H., Zhang L., Xie H., Zhao X., Wang F., Li Z., Wang Y., Ma S., Tao J., Wang W., Zhou Y., Yang W., and Cheng J. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells. J. Virol. 79 (2005) 14392-14403
15. Hadziyannis S.J. New developments in the treatment of chronic hepatitis B. Expert Opin. Biol. Ther. 6 (2006) 913-921
16. Hamasaki K., Nakao K., Matsumoto K., Ichikawa T., Ishikawa H., and Eguchi K. Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett. 543 (2003) 51-54
17. Hannon G.J. RNA interference. Nature 418 (2002) 244-251
18. Horiike N., Fazle Akbar S.M., Michitaka K., Joukou K., Yamamoto K., Kojima N., Hiasa Y., Abe M., and Onji M. In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B. J. Clin. Virol. 32 (2005) 156-161
19. Klein C., Bock C.T., Wedemeyer H., Wustefeld T., Locarnini S., Dienes H.P., Kubicka S., Manns M.P., and Trautwein C. Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology 125 (2003) 9-18
20. Konishi M., Wu C.H., and Wu G.Y. Inhibition of HBV replication by siRNA in a stable HBV-producing cell line. Hepatology 38 (2003) 842-850
21. Locarnini S., and Mason W.S. Cellular and virological mechanisms of HBV drug resistance. J. Hepatol. 44 (2006) 422-431
22. Lu M., Hilken G., Kruppenbacher J., Kemper T., Schirmbeck R., Reimann J., and Roggendorf M. Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection. J. Virol. 73 (1999) 281-289
23. Lu M., Isogawa M., Xu Y., and Hilken G. Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks. J. Virol. 79 (2005) 6368-6376
24. Lu M., Menne S., Yang D., Xu Y., and Roggendorf M. Immunomodulation as an option for the treatment of chronic hepatitis B virus infection: preclinical studies in the woodchuck model. Expert Opin. Investig. Drugs 16 (2007) 787-801
25. Lu M., Yao X., Xu Y., Lorenz H., Dahmen U., Chi H., Dirsch O., Kemper T., He L., Glebe D., Gerlich W.H., Wen Y., and Roggendorf M. Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck model. J.Virol. 82 (2008) 2598-2603
26. Malathi K., Dong B., Gale Jr. M., and Silverman R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448 (2007) 816-819
27. Mancini-Bourgine M., Fontaine H., Scott-Algara D., Pol S., Brechot C., and Michel M.L. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Hepatology 40 (2004) 874-882
28. Marcellin P. Advances in therapy for chronic hepatitis B. Semin. Liver Dis. 22 Suppl. 1 (2002) 33-36
29. McCaffrey A.P., Nakai H., Pandey K., Huang Z., Salazar F.H., Xu H., Wieland S.F., Marion P.L., and Kay M.A. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21 (2003) 639-644
30. Meng Z., Xu Y., Wu J., Tian Y., Kemper T., Bleekmann B., Roggendorf M., Yang D., and Lu M. Inhibition of hepatitis B virus gene expression and replication by endoribonuclease-prepared siRNA. J. Virol. Methods 150 (2008) 27-33
31. Menne S., Tennant B.C., Gerin J.L., and Cote P.J. Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein. J. Virol. 81 (2007) 10614-10624
32. Moroy T., Etiemble J., Trepo C., Tiollais P., and Buendia M.A. Transcription of woodchuck hepatitis virus in the chronically infected liver. EMBO J. 4 (1985) 1507-1514
33. Morrissey D.V., Blanchard K., Shaw L., Jensen K., Lockridge J.A., Dickinson B., McSwiggen J.A., Vargeese C., Bowman K., Shaffer C.S., Polisky B.A., and Zinnen S. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology 41 (2005) 1349-1356
34. Randall G., and Rice C.M. Interfering with hepatitis C virus RNA replication. Virus Res. 102 (2004) 19-25
35. Rehermann B. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses. Semin. Liver Dis. 27 (2007) 152-160
36. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., and Khvorova A. Rational siRNA design for RNA interference. Nat. Biotechnol. 22 (2004) 326-330
37. Roggendorf M., and Lu M. Woodchuck hepatitis virus. In: Thomas T.H., Zuckermann A., and Lemon S. (Eds). Viral Hepatitis. 3rd ed. (2005), Blackwell Publishing Ltd., Oxford 210-224
38. Seeger C., and Mason W.S. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64 (2000) 51-68
39. Shlomai A., and Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37 (2003) 764-770
40. Sledz C.A., Holko M., de Veer M.J., Silverman R.H., and Williams B.R. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5 (2003) 834-839
41. Stevenson M. Dissecting HIV-1 through RNA interference. Nat. Rev. Immunol. 3 (2003) 851-858
42. Stojdl D.F., Lichty B., Knowles S., Marius R., Atkins H., Sonenberg N., and Bell J.C. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat. Med. 6 (2000) 821-825
43. Summers J., Smolec J.M., and Snyder R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. U. S. A. 75 (1978) 4533-4537
44. Twu J.S., and Schloemer R.H. Transcription of the human beta interferon gene is inhibited by hepatitis B virus. J. Virol. 63 (1989) 3065-3071
45. Uprichard S.L., Boyd B., Althage A., and Chisari F.V. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 773-778
46. Vandepapeliere P., Lau G.K., Leroux-Roels G., Horsmans Y., Gane E., Tawandee T., Merican M.I., Win K.M., Trepo C., Cooksley G., Wettendorff M., and Ferrari C. Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine. Vaccine 25 (2007) 8585-8597
47. Waters J.A., O'Neill C., bdul-Gader A., Goldin R., Karayiannis P., and Monjardino J. Purification of woodchuck hepatitis surface antigen using a monoclonal antibody raised against the antigen. J. Virol. Methods 93 (2001) 97-103
48. Wu J., and Nandamuri K.M. Inhibition of hepatitis viral replication by siRNA. Expert. Opin. Biol. Ther. 4 (2004) 1649-1659
49. Wu H.L., Huang L.R., Huang C.C., Lai H.L., Liu C.J., Huang Y.T., Hsu Y.W., Lu C.Y., Chen D.S., and Chen P.J. RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. Gastroenterology 128 (2005) 708-716
50. Wu M., Xu Y., Lin S., Zhang X., Xiang L., and Yuan Z. Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1. J. Gen. Virol. 88 (2007) 3260-3269
51. Zhang Z., Protzer U., Hu Z., Jacob J., and Liang T.J. Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner. J. Virol. 78 (2004) 4566-4572
52. Zhang Z., Tian Y., Li L., Fiedler M., Schmid E., Roggendorf M., Xu Y., Lu M., and Yang D. A conserved linear B-cell epitope at the N-terminal region of woodchuck hepatitis virus core protein (WHcAg). J. Virol. Methods 135 (2006) 17-25
53. Zheng X., Schirmbeck R., Hilken G., Waters J.A., Yang D., Reimann J., Roggendorf M., and Lu M. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization. Virology 294 (2002) 342-353